The majority of weight loss medicines that are out there in today’s markets usually work by suppressing ones appetite and by speeding up your metabolism. But now there are studies being conducted at the University of Texas on monkeys which actually “kills” the monkey’s fat cells. The researchers believe that this drug may one day aid in the fight against obesity in overweight people. The drug that is under experiment at the present is called Adipotide and works by specifically focusing on the cells which are found in white fat tissue and attaching itself to fat cells in the blood and causing a synthetic protein reaction which causes the cell to die and soon afterwards these dead cells are reabsorbed by the body and metabolized for energy.
It was shown in a study that in just 4 weeks the fat monkeys being tested on at Texas University lost almost 12 percent of their body weight and specifically shed 27 percent of their abdominal fat. It is interesting to note said a scientist that those monkeys that were already thin did not lose any weight at all so this must mean that Adipotide must only focus on the extra fat stored.
This is wonderful news for those seeking to shed those extra pounds as there is only one FDA approved obesity drug on the market called Alli which stops the absorption of fat which people eat.
This discovery came as a result of scientist trying to develop methods for a more effective cancer treatment as the researchers believe that they could deprive tumors of their blood supply with a molecule that can target the code of the cells in our blood vessels that can feed cancerous growths and they conceive that they can also target the vessels that feed white fat cells which accumulate under the skin and specifically around the organs in the abdomen that are associated with weight gain.
So this new experimental drug Adipotide that is being tested at the University of Texas that can kill a type of fat cell by cutting of its blood supply and as a result can cause a significant loss in weight in obese monkeys and can potentially set the stage for a new drug approach in treating obesity.
It is also interesting to note that researchers commented that even after the initial treatment the monkeys health improved as their BMI and abdominal circumference continued to drop. The next step will be for these tests to be done on human patients and specifically those obese patients with prostate cancer since the prostate hormone therapy already add more weight and can bring more health risks to these already suffering patients.